CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Ventricular septal defect closure surgery +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05306483
NCT05306483N/ACompleted

Transcatheter Versus Surgical Closure of Ventricular Septal Defect: A Comparative Study

Ain Shams University·interventional·Posted Apr 1, 2022·Updated Apr 13, 2022

In Brief

A clinical study evaluating Ventricular septal defect closure surgery and Ventricular septal defect closure catheter for Heart Defects, Congenital. Completed, enrolled 72 participants across 1 site.

Detailed Summary

The aim of this study is to compare Safety, efiicacy and clinical effects of surgical versus transcatheter closure of ventricular septal defect (VSD ). The outcome of interest is success rate, residual shunts, effect on tricuspid and aortic valves, need for blood transfusion, length of hospital and intensive care unit ( ICU ) stay, complications especially complete heart block, affection of kidney functions due to the procedure length caused by Cardiopulmonary bypass in case of surgical group or by the dye used in the group of transcatheter closure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 1, 2022
Enrollment StartJun 12, 2020
Primary CompletionMar 15, 2021
Study CompletionJun 15, 2021
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.3 years ago

Interventions

Ventricular septal defect closure surgeryprocedure

Ventricular septal defect closure surgery

Ventricular septal defect closure catheterprocedure

Catheter closure of VSD